Journal of Research in Health Sciences
Volume:22 Issue: 2, Spring 2022

Monkeypox is a rare zoonotic infectious disease. Monkeypox virus belongs to the Orthopoxvirus genus of the Poxviridae family which includes both the variola (smallpox) virus and the Vaccinia virus (used in the smallpox vaccine)1. Monkeypox was initially discovered in 1958 and occurs mostly in Central and West Africa. Monkeypox is a global public health concern because more than 120 confirmed or suspected cases of the disease were recently identified in at least 11 non-endemic countries such as North America and Europe in May 20222, 3. Monkeypox is less contagious than smallpox. The virus enters the body through broken skin, the respiratory tract, or the mucous membranes (eyes, nose, or mouth)1. Human-to-human transmission occurs through direct contact with lesions, body fluids, and respiratory droplets. Prolonged face-to-face contact is required because respiratory droplets can only reach a few feet. Although almost all recently diagnosed cases include men aged 20 to 50, many of whom are men who have sex with men, it is unclear at this time if Monkeypox can be transmitted specifically through sexual transmission routes. Indirect contact with contaminated materials such as bedding has also been documented. Animal-to-human transmission may occur through a bite or scratch as well as direct or indirect contact with body fluids or lesion material2, 4, 5. Clinical presentations of Monkeypox are similar to but less severe than smallpox which was eradicated in 1980. The incubation period varies from 6 to 13 days but can take from 5 to 21 days. The disease is characterized by fever, headache, myalgia, backache, chills, exhaustion, and lymphadenopathy that may initially appear similar to chickenpox, measles, and smallpox. The illness typically lasts for 2 to 4 weeks1, 5. What should we do now to prevent the spread of Monkeypox and the possibility of an epidemic? Based on the limited information available at present, the risk of Monkeypox to the public is very low. Although containment strategies are not necessary at present time, however, the following measures that can be taken to prevent the silent spread of the disease1, 2, 5: (a) raising public awareness of risk factors and educating people about the measures they can take to reduce their exposure to the virus; (b) anyone who has clinical manifestations of Monkeypox should contact a health care provider right away; (c) isolation of suspected or confirmed cases of Monkeypox; (d) hand washing with soap and water or using an alcohol-based hand sanitizer immediately after unprotected contact with wild or sick animals or suspected patients or contaminated materials; (e) avoid contact with animals that could harbor the virus or direct contact with any contaminated materials such as bedding or laundry; (f) availability of laboratory equipment for confirmatory Monkeypox virus-specific testing on lesion specimens that clinicians obtain from suspected patients; (g) feasibility of access to suitable vaccine especially for high-risk people such as laboratory workers and health professionals as well as general population if necessary. According to the current knowledge, vaccines used during the smallpox eradication program also provide protection against Monkeypox. However, routine smallpox vaccination with vaccinia-based vaccines has been stopped by all countries at least 40 years ago. Therefore, unvaccinated populations, aged under 40, are now more susceptible to Monkeypox virus infection.

The highest-income countries procured 50 times as many COVID-19 vaccines as low-income countries, a global health inequity that resulted in only 4.6% of the poorest 5th of the world receiving a COVID-19 vaccine. High-income countries are considering vaccine mandates and passports to contain the spread of COVID-19. This study is a curated discourse aimed at examining how vaccine mandates and passports may impact global vaccine equity from an ethics perspective. Study Design: Narrative review adapted for a debate.

In November 2021, we conducted a review of studies examining global vaccine mandates for an upper-level global health course at Northeastern University, Boston, United States (U.S.). In total, 19 upper-level students, one research assistant, and one instructor participated in the data collection, analysis, and discussion.

The review showed vaccine mandates are ethical and effective if autonomy-centered alternatives like soft mandates are first exhausted. Unwarranted stringent public health measures degrade public trust. In the U.S. alone, COVID-19-related deaths hovered above 300 000 before COVID-19 vaccination began in mid-December 2020. Since then, the number of COVID-19 deaths more than doubled, despite the wide availability of the vaccine. For many low- and middle-income countries (LMICs) vaccines are not available or easily accessible. Global collaboration to facilitate vaccine availability in LMICs should be a priority.

It is essential to get as many people as possible vaccinated to return to some normality. However, vaccine mandates and passports need to be used only sparingly, especially when other options have been exhausted.

Glaucoma is a worldwide problem that causes vision loss and even blindness, with a prevalence rate ranging from 1.9% to 15%. In Ethiopia, glaucoma is the fifth cause of blindness. This study aimed to explore the dependence between blindness of the right and the left eyes of glaucoma patients and assess the effects of the covariates under the dependence structure. Study Design: A retrospective cohort study.

The study population included the glaucoma patients at Alert hospital from January 1, 2018, to December 30, 2021. The copula model was used to estimate the time to the blindness of the right and the left eyes of the glaucoma patients by specifying the dependence between the event times.

Out of 537 glaucoma patients, 224 (41.71%) became blind at least in one eye during the follow-up period. The results of the Clayton copula model revealed that factors, such as age, residence, diabetes mellitus, stage of glaucoma, and hypertension are considered the most prognostic factors for blindness in glaucoma patients. The findings also revealed that there was a strong dependence between the time to the blindness of the right and the left eyes in the glaucoma patients (τ = 0.43).

Based on the obtained results, high age, urban residence, hypertension, diabetes mellitus, and higher stage of glaucoma were factors associated with time to the blindness in the glaucoma patients. There was also a dependence between the right and the left eyes of the glaucoma patients. The results revealed that the Clayton Archimedean copula model was the best statistical model for accurate description of glaucoma patients’ datasets.

Glaucoma is a significant public health problem due to its substantial increase in the projected number of glaucoma cases. In Ethiopia, glaucoma accounts for 5.2% of irreversible blindness and is the fifth main cause of blindness. The main objective of this study was to modeling time to blindness of left and right eyes of glaucoma patients. Study Design: An institution-based retrospective cohort study.

This study was conducted among 315 glaucoma patients admitted to the Ophthalmology Department of Jimma University Medical Center (JUMC), Southwest Ethiopia, from January 1, 2016, to August 30, 2020. Kaplan-Meier survival analysis and semiparametric and parametric copula models were applied to identify factors that affect time to the blindness in glaucoma patients and the dependence between time to the blindness of the left and right eyes, respectively. An Akaike information criterion (AIC) was used to select the best non-nested model.

In total, 211 (66.9%) out of 315 glaucoma patients were blind, whereas 104 (33.1%) patients were censored. The median time to the blindness of the left and right eyes was determined to be 12 months. The result suggested that the risk of the blindness in male patients was 1.005 (P = 0.01) times higher than that in female patients, and the risk of the blindness in patients who had early, moderate, and advanced glaucoma was estimated to be 0.582 (P = 0.002), 0.485 (P = 0.001) and 0.887 (P = 0.003) times less than that in the patients with absolute glaucoma, respectively.

Age, place of residence, gender, type of medication, diabetes disease, stage of glaucoma, duration of treatment, intraocular pressure (IOP), and cup-disk ratio were significantly associated with and affected by the time to the blindness of left and right eyes in glaucoma patients. Awareness should be given to the community to reduce the burden of glaucoma.

Kidney failure is a common public health problem around the world. The vast majority of kidney failure cases in Sub-Saharan African nations, including Ethiopia, go undetected and untreated, resulting in practically certain mortality cases. This study was aimed primarily to model the time to (right and left) kidneys failure in the patients at Adama Hospital Medical College using the copula model. Study design: A retrospective cohort study.

The copula model was used to examine join time to the right and left kidneys failure in the patients by specifying the dependence between the failure times. We employed Weibull, Gompertz, and Log-logistic marginal baseline distributions with Clayton, Gumbel, and Joe Archimedean copula families.

This research comprised a total of 431 patients, out of which, 170 (39.4%) of the total patients failed at least one kidney during the follow-up period. Factors such as sex, age, family history of kidney disease, diabetes mellitus, hypertension, and obesity were found to be the most predictive variables for kidney failure in the patients. There was a 41 percent correlation between the patients’ time to the right and left kidneys failure.

The patients’ kidney failure risk factors included being a male, older adult, obese, hypertensive, diabetic and also having a family history of kidney disease. The dependence between the patient’s time to the right and left kidneys failure was strong. The best statistical model for describing the kidney failure datasets was the log-logistic-Clayton Archimedean copula model.

Exposure to crystalline silica has long been identified to be associated with lung diseases. Therefore, the present study aimed to assess the risk of silicosis and lung cancer associated with occupational exposure to crystalline silica in Iran. Study Design: It is a systematic review study.

Different databases were searched, and the Cochrane method was used for the systematic review. Thereafter, cumulative exposure to crystalline silica (mg/m3-y) was calculated in every industry. The relative risk of death from silicosis was performed using Mannetje’s method. Based on the geometric mean of exposure, the lung cancer risk of exposure to crystalline silica was also calculated.

As evidenced by the results, worker’s exposure to silica ranged from a geometric mean of 0.0212- 0.2689 mg/m3 (Recommended standard by the American Conference of Governmental Industrial Hygienists (ACGIH) was 0.025 mg/m3), which is generally higher than the occupational exposure limit recommended by National Institute for Occupational Safety and Health (NIOSH), ACGIH, and occupational exposure limits. The relative risk of silicosis was in the range of 1 to 14 per 1000 people, and the risk of lung cancer in workers ranged from 13-137 per 1000 people.

Since workers are at considerable risk of cancer due to exposure to silica in Iran, exposure control programs need to be implemented in workplaces to decrease the concentration of silica.

Healthcare workers (HCWs) run a high risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The HCWs are prone to the SARS-CoV-2 infection in the hospital despite being fully vaccinated. The present study aimed to address the factors associated with the coronavirus disease 2019 (COVID-19) vaccine breakthrough among HCWs. Study Design: A prospective cohort study.

Participants were 184 HCWs receiving two doses of inactivated SARS-CoV-2 vaccine (CoronaVac, Sinovac Life Science). All participants were followed for six months. Confirmed COVID-19 was defined as positive SARS-CoV-2 by reverse transcription-polymerase chain reaction (RT-PCR). Before undergoing RT-PCR, questionnaires were used to obtain information on demographic characteristics, profession, contact with COVID-19 cases, personal protective equipment (PPE), health protocols adherence, exercise, and nutritional habits.

A number of 57 (31%) participants were COVID-19 positive. Close contact with COVID-19 cases (adjusted RR 6.82, 95% CI: 1.97, 47.98, P = 0.044), being a resident doctor (adjusted RR 4.72, 95% CI: 1.11, 20.11, P = 0.036), improper mask-wearing (adjusted RR 2.36, 95% CI: 1.15, 4.85, P = 0.019), and lower frequency of eating fruit and vegetables (adjusted RR 2.73, 95% CI: 1.34, 5.57, P = 0.006) increased the risk of vaccine breakthrough. Compared to single surgical masks, KN95 and N95 significantly reduced the risk of COVID-19 (adjusted RR 0.27, 95% CI: 0.07, 0.97, P = 0.045 and adjusted RR 0.25, 95% CI: 0.07, 0.87, P = 0.029), respectively.

As evidenced by the obtained results, being a resident doctor, close contact with confirmed COVID-19 cases, health protocol incompliance, as well as the lower frequency of fruit and vegetable consumption were associated with the risk of vaccine breakthrough among HCWs. Appropriate strategies are needed to prevent the risk of SARS-CoV-2 infection among HCWs.

Cervical cancer, the most common gynecological cancer, is a matter of concern, especially in developing countries. The present study investigates survival rates, associated factors, and post-treatment follow-up status in cervical cancer patients. Study Design: A retrospective cohort study.

This study was conducted on 187 patients referred to an academic referral cancer center in Iran from 2014-2020. Overall survival (OS) and event-free survival (EFS) were evaluated using Kaplan Meyer analysis. The event was defined as recurrence, metastasis, or death.

The patients came for post-treatment visits for a median of 36 months (interquartile range [IQR]: 18-51). The median OS and EFS were 24 and 18 months, respectively. The 1- and 3- year OS rates were 90% and 72%, respectively. The 1- and 3- year EFS rates were 76% and 61%, respectively. Stage ≥ III (hazard ratio [HR]: 3.1, 95% confidence interval [CI]: 1.5, 6.5, P < 0.001) and tumor size > 4 cm (HR: 2.5, 95% CI: 1.2, 4.9, P = 0.006) predicted lower OS. The most common histopathology was squamous cell carcinoma (SCC) (71.1%) with non-significant higher 3- year OS (HR: 0.62, 95% CI: 0.33, 1.16, P = 0.13). No significant difference in OS was found between adjuvant and definitive radiotherapy in both early and advance-staged patients (Log-rank = 0.7 P = 0.4, log-rank = 1.6, P = 0.2, respectively).

As evidenced by the obtained results, the survival of patients was lower compared to that in developed countries. Higher stage and tumor size led to shorter survival. The histopathology and type of treatment in comparable stages did not have any significant impact on survival.